Mochida Pharmaceutical is a leading Japanese pharmaceutical company focused on the research, development, and distribution of specialized medicines. Its core business areas include dermatology, internal medicine, and psychiatry. Additionally, the company is engaged in the distribution of medical equipment.
Date confirmed from the Tokyo Stock Exchange (JPX) announcement schedule.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Mochida Pharmaceutical is scheduled to report its next quarterly earnings on 11/09/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Mochida Pharmaceutical last reported quarterly earnings on 8/3/2026 (Q2 2026). Earnings per share (EPS) came in at 89.77 JPY.
Across its last 3 earnings reports, Mochida Pharmaceutical stock moved by ±2.3% on average the following day. The largest reaction was -2.5% on 02/06/2026; 2 of 3 reactions were positive.
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Past price reactions are not a reliable indicator of future performance.